Search - tctmd.com

Displaying 501 - 520 of 1021

Sort: Relevancy | Date

Presentation THT 2024

CoreWave: A Novel Pump Concept

Presenter: Palak Shah

March 04, 2024

Presentation THT 2024

BrioHealth Solutions: Pump and Clinical Trial Design

Presenter: James Long

March 04, 2024

Presentation THT 2024

Early Experience With IMPELLA RP Flex

Presenter: Kanika P. Mody

March 04, 2024

Presentation THT 2024

Durable LVADs: Pump Innovations Required to Advance the Field

Presenter: Francis D. Pagani

March 04, 2024

Presentation THT 2024

Contemporary Pharmacological Therapies for Acute Heart Failure

Presenter: Wilfried Mullens

March 04, 2024

Presentation THT 2024

Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization

Presenter: Gad Cotter

March 04, 2024

Presentation THT 2024

The Future of Heart Failure Trials: Faster, Better and More Efficient Approaches to Approvals

Presenter: Scott Solomon

March 04, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

Presentation THT 2024

New Approaches to Treating Heart Failure

Presenter: W. H. Wilson Tang

March 04, 2024

Presentation THT 2024

How I Manage AMI-Shock in 2024

Presenter: Dirk Westermann

March 04, 2024

Presentation THT 2024

3000 Years in the Making: Traditional Chinese Herbal Medicines for Heart Failure

Presenter: Milton Packer

March 04, 2024

Presentation THT 2024

The OBESITY-HF Connection: Time to Attack This Head-on

Presenter: Barry Borlaug

March 04, 2024

Presentation THT 2024

How CRISPR Will Be Used to Prevent Heart Failure

Presenter: Christine Seidman

March 04, 2024

Presentation THT 2024

Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: William T. Abraham

March 04, 2024

Presentation THT 2024

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: JoAnn Lindenfeld

March 04, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Presenter: Sheldon E. Litwin

March 04, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis

Presenter: Marat Fudim

March 04, 2024

Presentation THT 2024

Investigating the Efficacy of Transfer Learning for the Detection of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Patients: An Experimental Approach

Presenter: Kyung-Hee Kim

March 04, 2024

Presentation THT 2024

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Presenter: Nadira Hamid

March 04, 2024

Presentation THT 2024

Future Care in HF: Sensors, Artificial Intelligence, and Medicine

Presenter: Jagmeet P. Singh

March 04, 2024

Advertisement

CoreWave: A Novel Pump Concept

BrioHealth Solutions: Pump and Clinical Trial Design

Early Experience With IMPELLA RP Flex

Durable LVADs: Pump Innovations Required to Advance the Field

Contemporary Pharmacological Therapies for Acute Heart Failure

Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization

The Future of Heart Failure Trials: Faster, Better and More Efficient Approaches to Approvals

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

New Approaches to Treating Heart Failure

How I Manage AMI-Shock in 2024

3000 Years in the Making: Traditional Chinese Herbal Medicines for Heart Failure

The OBESITY-HF Connection: Time to Attack This Head-on

How CRISPR Will Be Used to Prevent Heart Failure

Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis

Investigating the Efficacy of Transfer Learning for the Detection of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Patients: An Experimental Approach

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Future Care in HF: Sensors, Artificial Intelligence, and Medicine

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content